Profile data is unavailable for this security.
About the company
Mabion SA is a Poland-based biopharmaceutical company. The Company provides a broad spectrum of services in the segment of small and medium-sized projects at various stages of development (from early-stage discovery to commercial manufacturing). The Company's competencies include the selection of protein expression technologies, their purification, GMP-standard manufacturing activities (obtaining Active Substances - Drug Substance and Finished Products - Drug Product), development of analytical tools (for structural, functional, physicochemical characterization), clinical development, clinical analytics and a full range of regulatory activities in the development and operational areas. The Company's goal is to establish itself as a recognizable player in the global contract manufacturing and contract drug development market and to complete its full transformation into an integrated biologics CDMO company.
- Revenue in PLN (TTM)14.81m
- Net income in PLN-59.30m
- Incorporated2009
- Employees204.00
- LocationMabion SAgen. Mariana Langiewicza 60KONSTANTYNOW LODZKI 95-050PolandPOL
- Phone+48 422077890
- Fax+48 422032703
- Websitehttps://www.mabion.eu/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicofarma Biotech SA | 281.45k | -3.06m | 33.24m | 24.00 | -- | 6.99 | -- | 118.11 | -0.0450 | -0.0450 | 0.0041 | 0.07 | 0.0199 | 66.64 | 0.7469 | 11,727.08 | -21.55 | -14.96 | -31.48 | -18.59 | 38.80 | 36.02 | -1,085.51 | -64.02 | 0.821 | -11.71 | 0.00 | -- | 63.14 | -17.39 | 33.11 | -- | -- | -- |
| GENOMED SA | 27.49m | 3.27m | 38.05m | 53.00 | 11.63 | 3.06 | 9.44 | 1.38 | 2.48 | 2.48 | 20.81 | 9.42 | 2.21 | 5.17 | 12.68 | 509,166.10 | 26.31 | 7.51 | 28.79 | 8.81 | 65.24 | 62.33 | 11.90 | 3.84 | 7.51 | -- | 0.00 | -- | 2.34 | 3.18 | 19.32 | 1.98 | 15.97 | -- |
| Sds Optic SA | 7.44m | -483.71k | 49.14m | 41.00 | -- | 50.04 | 223.11 | 6.60 | -0.0815 | -0.0815 | 1.25 | 0.1559 | 0.5497 | 5.12 | 125.84 | 181,486.60 | -4.01 | -32.89 | -4.24 | -41.35 | 98.19 | 49.49 | -7.29 | -136.62 | 2.50 | 0.6278 | 0.00 | -- | 40.53 | 301.05 | -45.06 | -- | 57.27 | -- |
| Sygnis SA | 7.73m | -6.34m | 57.60m | 12.00 | -- | 1.79 | -- | 7.45 | -0.2499 | -0.2499 | 0.3309 | 1.17 | 0.1166 | -0.1689 | 6.14 | 218,427.70 | -9.03 | -8.61 | -15.00 | -12.10 | 108.49 | 59.85 | -77.44 | -39.14 | 0.6697 | -0.0066 | 0.13 | -- | -52.29 | 26.88 | -47.44 | -- | -9.50 | -- |
| Read Gene SA | 15.19m | -887.46k | 61.31m | 11.00 | -- | 22.88 | -- | 4.04 | -0.0536 | -0.0536 | 1.17 | 0.2273 | 1.08 | 39.77 | 6.30 | -- | -6.32 | -2.40 | -6.88 | -2.74 | 92.63 | 90.21 | -5.84 | -4.30 | 6.31 | -0.696 | 0.00 | -- | 30.38 | 26.38 | 17.49 | -- | -- | -- |
| Genomtec SA | 15.00k | -11.01m | 69.00m | -- | -- | 6.67 | -- | 4,599.74 | -0.7485 | -0.7485 | 0.001 | 0.6869 | 0.0009 | -- | 0.0143 | -- | -65.47 | -89.96 | -82.11 | -113.38 | -54,120.00 | -4,379.72 | -73,393.34 | -17,225.07 | 2.82 | -39.82 | 0.1409 | -- | 0.00 | -63.42 | -24.35 | -- | -34.54 | -- |
| Hyenergy SA | 3.29m | 169.85k | 77.91m | 27.00 | -- | 3.95 | 318.90 | 23.69 | -0.0936 | -0.0936 | 0.1654 | 0.5878 | 0.1821 | 0.1259 | 0.7741 | -- | 0.9403 | 2.39 | 1.28 | 3.35 | 99.70 | 77.46 | 5.16 | 3.11 | 1.30 | 1.17 | 0.00 | -- | 192.83 | 19.47 | 100.30 | -- | -45.79 | -- |
| Urteste SA | 0.00 | -5.47m | 83.93m | 34.00 | -- | 3.58 | -- | -- | -3.88 | -3.88 | 0.00 | 15.35 | 0.00 | -- | -- | -- | -15.56 | -29.65 | -18.99 | -31.35 | -- | -45,933.33 | -- | -623,333.30 | -- | -- | 0.0128 | -- | -- | -- | 35.00 | -- | 197.79 | -- |
| Nanogroup SA | -6.90k | -6.93m | 84.04m | -- | -- | 7.21 | -- | -- | -0.1844 | -0.1844 | -0.0002 | 0.3553 | -0.0003 | 2.64 | -- | -- | -30.59 | -29.50 | -51.55 | -33.80 | -- | 66.72 | -- | -2,258.26 | 0.9785 | -464.18 | 0.00 | -- | 3.96 | -64.09 | 34.50 | -- | 3.07 | -- |
| Poltreg SA | 0.00 | -24.56m | 120.78m | 33.00 | -- | 2.44 | -- | -- | -5.27 | -5.27 | 0.00 | 10.61 | 0.00 | 16.45 | -- | 0.00 | -25.87 | -9.02 | -29.62 | -10.18 | -- | -659.36 | -- | -854.23 | 2.65 | -- | 0.1365 | -- | -74.98 | -6.89 | -38.06 | -- | 83.47 | -- |
| Mabion SA | 14.81m | -59.30m | 132.69m | 204.00 | -- | 1.90 | -- | 8.96 | -3.67 | -3.67 | 0.9164 | 4.33 | 0.0988 | 8.10 | 27.25 | 72,602.94 | -39.56 | 0.5366 | -54.81 | 1.06 | -178.55 | 58.34 | -400.37 | 0.9643 | 0.2276 | -- | 0.04 | -- | -54.50 | -- | -115.35 | -- | 6.00 | -- |
| Molecure SA | 5.11m | -24.42m | 139.48m | 71.00 | -- | 1.56 | -- | 27.28 | -1.20 | -1.20 | 0.2493 | 4.34 | 0.0553 | -- | 7.01 | 50,119.41 | -26.42 | -3.15 | -27.53 | -3.30 | 51.48 | 93.34 | -477.67 | -15.45 | -- | -- | 0.0588 | -- | -40.47 | 278.20 | -10.27 | -- | 12.49 | -- |
| BIOTON SA | 295.81m | -2.82m | 337.45m | 363.00 | -- | 0.5699 | 9.54 | 1.14 | -0.0329 | -0.0329 | 3.45 | 6.90 | 0.3814 | 2.02 | 8.84 | 814,906.30 | -0.3638 | 0.5935 | -0.4325 | 0.7338 | 29.69 | 41.35 | -0.954 | 2.47 | 0.5186 | 1.64 | 0.0682 | 0.00 | 14.38 | 0.561 | -788.26 | -- | -26.87 | -- |
Data as of Feb 06 2026. Currency figures normalised to Mabion SA's reporting currency: Polish New Zloty PLN
2.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Generali PTE SAas of 31 Dec 2024 | 358.96k | 2.22% |
| AgioFunds TFI SAas of 30 Dec 2025 | 67.63k | 0.42% |
| Investors TFI SAas of 30 Jun 2025 | 48.94k | 0.30% |
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 407.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 08 Jan 2026Source: FactSet Research Systems Inc.
